ReviewJournal of endocrinological investigation2014
Management of craniopharyngiomas.
Review in Journal of endocrinological investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.
- Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of long-term follow-up.BMC cancer · 2024Pooled it
- Brachytherapy in paediatric craniopharyngiomas: a systematic review and meta-analysis of recent literature.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2022Pooled it
- Article
- Pharmacological Treatment for Adamantinomatous Craniopharyngioma.Current oncology reports · 2025Review
- Advances in the Management of Craniopharyngioma: A Narrative Review of Recent Developments and Clinical Strategies.Journal of clinical medicine · 2025Review
- Review
- Ferroptosis-related biomarkers for adamantinomatous craniopharyngioma treatment: conclusions from machine learning techniques.Frontiers in endocrinology · 2024Article
- Risk-benefit analysis of surgical treatment strategies for cystic craniopharyngioma in children and adolescents.Frontiers in oncology · 2024Article
- Clinical and oncological outcomes in single-stage versus staged surgery for pediatric craniopharyngiomas: a multicenter retrospective study.Journal of endocrinological investigation · 2023Article
- A promising future for hypothalamic dysfunction in craniopharyngioma.Neuro-oncology · 2023Article
- The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas.Current oncology (Toronto, Ont.) · 2022Review
- Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.Frontiers in oncology · 2022Article
- An endoscopic endonasal approach to craniopharyngioma via the infrachiasmatic corridor: a single center experience of 84 patients.Acta neurochirurgica · 2021Article
- Epidemiology of craniopharyngiomas: a population-based study in Malta.Endocrine oncology (Bristol, England) · 2021Article
- Endocrine Disorder in Patients With Craniopharyngioma.Frontiers in neurology · 2021Review
- Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.Experimental and therapeutic medicine · 2019Article
- Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.Endocrine · 2017Article
- Review
- Recent advances in molecular pathology of craniopharyngioma.F1000Research · 2017Review
- Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.Journal of neuro-oncology · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Craniopharyngiomas are rare epithelial tumours arising along the path of the craniopharyngeal duct. Their pathogenesis remains uncertain and they can present with a variety of manifestations attributed to pressure effects to surrounding structures. The optimal management of craniopharyngiomas remains challenging mainly due to their sharp, irregular borders and their tendency to adhere to vital neurovascular structures making surgical manipulations potentially hazardous to vital brain areas. Non-aggressive surgery followed by radiotherapy is currently the most widely used option possibly achieving the most optimal long-term outcome. Other treatment modalities including intracystic irradiation, intracystic instillation of antineoplasmatic agents and stereotactic radiotherapy are also available in our armamentarium. The long-term morbidities related with the craniopharyngiomas and their treatment remain significant, with hypothalamic damage playing the protagonist role and requiring further studies to identify measures that will improve the prognosis of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.